Semaglutide
Published date: 2026-05-21 17:18:00
|
Name | Semaglutide acetate salt | CAS# | 910463-68-2 |
|---|---|---|---|---|
| Price | $468.82/10mg $7288.78/1g | Purity | 99.54% | |
| Stocking Period |
3 Day | Stock | In Stock | |
| Product Webpage: | http://www.zhaokebio.com | |||
| Detail
Product Information
Product Name：Semaglutide CAS No：910463-68-2 Positioning：Exclusively tailored peptide API for Shenzhen Zhaoke, produced with 28 years of focus on peptide innovation. As a high-purity GLP-1 receptor agonist, it focuses on the metabolic disease field, relying on AI intelligent drug technology and the entire industrial chain advantage to provide core raw materials for Shenzhen Zhaoke's innovative formulation R&D and help expand the global metabolic drug market. Key Selling Points • Precise Targeting & Excellent Efficacy: A GLP-1 receptor agonist with potent glycemic control and significant weight loss effects, suitable for type 2 diabetes, obesity and other metabolic diseases, matching Shenzhen Zhaoke's R&D layout. • High-Standard Quality Control: Based on mature peptide synthesis technology, it features high purity, stable activity, uniform batches and strictly controllable impurities, supporting rapid compliance declaration of formulations. • FDA-Compliant & Globally Adaptable: International GMP quality system supports Shenzhen Zhaoke's domestic and foreign formulation registration, helping products enter more than 90 countries and regions worldwide. • One-Stop CRDMO Services: Covering API synthesis, formulation design, process development and regulatory filing to accelerate product launch. Target Formulations • Semaglutide Injection (prefilled pen/prefilled syringe/vial, mainstream dosage form for routine clinical use); • Long-Acting Weekly Formulations (reducing medication frequency, improving patient compliance and enhancing product competitiveness); • High-Concentration Formulations for Weight Loss (meeting the needs of obese populations and expanding application scenarios); • Compound Formulations for Metabolic Diseases (combining with other hypoglycemic/weight-loss drugs to expand indications, adapting to Shenzhen Zhaoke's diversified layout). Shenzhen Zhaoke Biotechnology Co., Ltd. operates as a specialized global procurement and supply chain solutions provider focused exclusively on high-quality peptide APIs. Rather than manufacturing, our core competency lies in strategically sourcing, rigorously vetting, and reliably delivering premium peptide products from qualified suppliers across the global pharmaceutical landscape. We serve as the critical link between world-class peptide producers and pharmaceutical R&D enters, research institutions, and manufacturing enterprises across North America, Europe, Asia Pacific, and emerging markets. Our mission is to eliminate procurement complexity, mitigate supply risk, and ensure uncompromising quality at every stage of the sourcing journey. |